share_log

Wealthfront Advisers LLC Buys New Shares in Teladoc Health, Inc. (NYSE:TDOC)

Wealthfront Advisers LLC Buys New Shares in Teladoc Health, Inc. (NYSE:TDOC)

Wealthront Advisers LLC購買Teladoc Health,Inc.(紐約證券交易所代碼:TDOC)的新股
Defense World ·  2022/10/02 06:51

Wealthfront Advisers LLC bought a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 81,183 shares of the health services provider's stock, valued at approximately $2,696,000. Wealthfront Advisers LLC owned 0.05% of Teladoc Health as of its most recent SEC filing.

Wealthront Advisers LLC在第二季度購買了Teladoc Health,Inc.(紐約證券交易所代碼:TDOC-GET Rating)的新股,該公司在最近提交給美國證券交易委員會的文件中説。該基金購買了這家醫療服務提供商的81,183股票,價值約2,696,000美元。截至最近提交的美國證券交易委員會申請文件,Wealthfront Advisers LLC擁有Teladoc Health 0.05%的股份。

Other institutional investors also recently modified their holdings of the company. DB Wealth Management Group LLC acquired a new position in Teladoc Health during the first quarter worth $25,000. McCarthy Asset Management Inc. acquired a new position in Teladoc Health during the first quarter worth $25,000. Oliver Lagore Vanvalin Investment Group acquired a new position in Teladoc Health during the first quarter worth $27,000. City State Bank acquired a new position in Teladoc Health during the fourth quarter worth $27,000. Finally, GoalVest Advisory LLC acquired a new position in Teladoc Health during the first quarter worth $31,000. Institutional investors and hedge funds own 92.46% of the company's stock.

其他機構投資者最近也調整了對該公司的持股。DB Wealth Management Group LLC在第一季度收購了Teladoc Health的一個新頭寸,價值2.5萬美元。麥卡錫資產管理公司在第一季度收購了Teladoc Health的一個新頭寸,價值2.5萬美元。Oliver LaGore Vanvalin投資集團在第一季度收購了Teladoc Health的一個新頭寸,價值2.7萬美元。城市國家銀行在第四季度收購了Teladoc Health的一個新頭寸,價值2.7萬美元。最後,GoalVest Consulting LLC在第一季度收購了Teladoc Health的一個新頭寸,價值3.1萬美元。機構投資者和對衝基金持有該公司92.46%的股票。

Get
到達
Teladoc Health
Teladoc Health
alerts:
警報:

Analyst Upgrades and Downgrades

分析師升級和下調評級

TDOC has been the topic of several research reports. Truist Financial initiated coverage on shares of Teladoc Health in a report on Wednesday, September 7th. They set a "hold" rating and a $35.00 price objective on the stock. Piper Sandler lowered their price objective on shares of Teladoc Health from $42.00 to $40.00 and set an "overweight" rating on the stock in a report on Thursday, July 28th. Royal Bank of Canada lowered their target price on shares of Teladoc Health from $53.00 to $35.00 in a report on Wednesday. Cowen downgraded shares of Teladoc Health from an "outperform" rating to a "market perform" rating and lowered their target price for the company from $58.00 to $34.00 in a report on Tuesday, August 2nd. Finally, Stifel Nicolaus lowered their target price on shares of Teladoc Health from $36.00 to $30.00 in a report on Thursday, July 28th. Two analysts have rated the stock with a sell rating, twenty-four have issued a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $64.13.

TDOC一直是幾份研究報告的主題。Truist Financial在9月7日星期三的一份報告中啟動了對Teladoc Health股票的報道。他們為該股設定了“持有”評級和35.00美元的目標價。派珀·桑德勒在7月28日週四的一份報告中將Teladoc Health的股票目標價從42.00美元下調至40.00美元,並對該股設定了“增持”評級。加拿大皇家銀行在週三的一份報告中將Teladoc Health的目標價從53.00美元下調至35.00美元。在8月2日週二的一份報告中,Cowen將Teladoc Health的股票評級從“跑贏大盤”下調至“市場表現”,並將該公司目標價從58.00美元下調至34.00美元。最後,Stifel Nicolaus在7月28日星期四的一份報告中將Teladoc Health的目標股價從36.00美元下調至30.00美元。兩名分析師對該股的評級為賣出,24名分析師對該股給予持有評級,五名分析師對該股給予買入評級。根據MarketBeat.com的數據,該股目前的平均評級為持有,共識目標價為64.13美元。

Insider Buying and Selling

內幕買賣

In related news, SVP Daniel Trencher sold 1,000 shares of the company's stock in a transaction that occurred on Monday, September 19th. The shares were sold at an average price of $30.18, for a total transaction of $30,180.00. Following the sale, the senior vice president now owns 25,408 shares of the company's stock, valued at approximately $766,813.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through
在相關新聞中,高級副總裁Daniel·特倫徹在9月19日星期一的一筆交易中出售了1,000股該公司股票。這些股票的平均價格為30.18美元,總成交金額為30,180.00美元。出售後,高級副總裁現在擁有該公司25,408股股票,價值約76.6813.44美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過
. In related news, SVP Daniel Trencher sold 1,000 shares of the company's stock in a transaction that occurred on Monday, September 19th. The shares were sold at an average price of $30.18, for a total transaction of $30,180.00. Following the sale, the senior vice president now owns 25,408 shares of the company's stock, valued at approximately $766,813.44. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through
。在相關新聞中,高級副總裁Daniel·特倫徹在9月19日星期一的一筆交易中出售了1,000股該公司股票。這些股票的平均價格為30.18美元,總成交金額為30,180.00美元。出售後,高級副總裁現在擁有該公司25,408股股票,價值約76.6813.44美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過
. Also, insider Arnnon Geshuri sold 4,098 shares of the stock in a transaction on Friday, August 26th. The stock was sold at an average price of $34.27, for a total transaction of $140,438.46. Following the completion of the transaction, the insider now directly owns 76,182 shares in the company, valued at approximately $2,610,757.14. The disclosure for this sale can be found
。此外,內部人士阿農·格舒裏在8月26日(星期五)的一次交易中出售了4098股該股。該股以34.27美元的平均價格出售,總成交金額為140,438.46美元。交易完成後,該內部人士現在直接擁有該公司76,182股,價值約2,610,757.14美元。關於這次銷售的披露可以找到
. In the last 90 days, insiders have sold 7,318 shares of company stock valued at $255,321. Company insiders own 1.55% of the company's stock.
。在過去的90天裏,內部人士已經出售了7318股公司股票,價值255,321美元。公司內部人士持有該公司1.55%的股份。

Teladoc Health Stock Down 3.4 %

Teladoc Health股票下跌3.4%

TDOC stock opened at $25.35 on Friday. The firm has a 50 day moving average of $33.43 and a 200-day moving average of $41.33. Teladoc Health, Inc. has a 12 month low of $25.33 and a 12 month high of $156.82. The company has a debt-to-equity ratio of 0.25, a quick ratio of 3.22 and a current ratio of 3.38.

上週五,TDOC股價開盤報25.35美元。該公司的50日移動均線切入位在33.43美元,200日移動均線切入位在41.33美元。Teladoc Health,Inc.的12個月低點為25.33美元,12個月高位為156.82美元。該公司的負債權益比率為0.25,速動比率為3.22,流動比率為3.38。

Teladoc Health (NYSE:TDOC – Get Rating) last posted its earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share for the quarter, topping analysts' consensus estimates of ($0.71) by $0.27. The business had revenue of $592.38 million for the quarter, compared to analyst estimates of $586.86 million. Teladoc Health had a negative net margin of 441.94% and a negative return on equity of 2.04%. Equities analysts expect that Teladoc Health, Inc. will post -1.54 EPS for the current fiscal year.

Teladoc Health(紐約證券交易所代碼:TDOC-GET Rating)最近一次公佈收益結果是在7月27日星期三。這家醫療服務提供商公佈了該季度每股收益(0.44美元),比分析師普遍預期的(0.71美元)高出0.27美元。該業務本季度營收為5.9238億美元,而分析師預期為5.8686億美元。Teladoc Health的淨利潤率為負441.94%,淨資產回報率為負2.04%。股票分析師預計,Teladoc Health,Inc.本財年每股收益將達到1.54美元。

About Teladoc Health

關於Teladoc Health

(Get Rating)

(獲取評級)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Teladoc Health,Inc.在美國和國際上提供虛擬醫療服務。該公司提供一系列服務和解決方案,涵蓋非緊急、間歇性、慢性和複雜的醫療狀況,包括糖尿病、高血壓、慢性腎臟疾病、癌症、充血性心力衰竭和精神健康狀況。

Featured Articles

專題文章

  • Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
  • Thor Industries Hammers Out A Bottom
  • 免費獲取StockNews.com關於Teladoc Health(TDOC)的研究報告
  • 電動汽車電池製造商Freyr將在全球大舉擴張
  • MarketBeat:回顧一週9/26-9/30
  • 這是買入美光科技的難忘時刻
  • Keurig Dr Pepper與規模更大的競爭對手可口可樂(Coke&Pepsi)相比如何?
  • 雷神工業走出谷底

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Get Rating).

想看看其他對衝基金持有TDOC的情況嗎?訪問HoldingsChannel.com獲取Teladoc Health,Inc.(紐約證券交易所代碼:TDOC-GET Rating)的最新13F文件和內幕交易信息。

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

接受Teladoc健康日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Teladoc Health和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論